Immune checkpoint inhibition and cardiovascular toxicity
Event: ESC Congress 2023
Topic: Basic Science
Session: Translational insights from cardioimmunology for human heart failure
Shared mechanisms in heart failure and cancer.
Event: ESC Congress 2020
Topic: Cardio-Oncology
Session: Cardio-oncology in Focus
Cardiomyopathy development following breast cancer treatment: restratification.
Event: ESC Congress 2020
Topic: Basic Science, Other
Session: Mechanisms of Chemotherapy-Induced Cardiotoxicity
Can we prevent toxicity of immune checkpoint inhibitors?
Event: ESC Congress 2020
Topic: Basic Science
Session: Cardio-Oncology: More Than Cardiotoxicity
A patient with cancer, arrhythmias and heart failure: optimal clinical approach?
Event: Heart Failure 2020
Topic: Chronic Heart Failure, Other
Session: HFA Focus: challenging clinical scenarios in heart failure
Immunotherapy: between hope and hype?
Event: Heart Failure 2020
Topic: Cardio-Oncology
Session: Cardio-oncology: linking the heart and cancer
Challenges in the long-term follow-up of cardio-oncology patients.
Event: ESC Congress 2019
Topic: Cardio-Oncology
Session: Cardiovascular health in cancer patients and survivors
Cardiovascular toxicity associated with immune checkpoint inhibitors.
Event: ESC Congress 2019
Topic: Cardio-Oncology
Session: Cardio-oncology: what every cardiologist should know about cardiovascular effects of cancer treatment
Cardiovascular side effects of anti-tumor drugs.
Event: ESC Congress 2019
Topic: Basic Science, Other
Session: Cardio-Oncology: Novel mechanisms and clinical implications
Immunotherapy associated cardiotoxicity: pathophysiology, detection and treatment strategies
Event: Heart Failure 2019
Topic: Cardiotoxicity of Drugs and Other Therapies
Session: Special issues in cardio-oncology
ESC 365 is supported by
